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Hospitals and health systems in high-income 
countries (HIC) develop the capacities of peer 
healthcare organizations around the world by diffusing 
clinical, quality, and public health improvement 
practices in lower and middle-income countries 
(LMIC). In turn, these HIC healthcare institutions are 
exposed to innovative approaches developed and used 
by global communities to advance care despite 
resource constraints in the LMIC contexts. Attention 
has been growing in recent years to the potential these 
innovations can have to improve care delivery, lower 
costs, and drive quality within resource constrained 
communities in HIC. Often referred to as ‘reverse 
innovations,’ the identification, adaptation, and 
diffusion of these practices face challenges in uptake 
related to limited evidence, perceptions of poor quality 
or irrelevance, and a complicated regulatory and 
policy environment. This paper suggests the 
development of a knowledge platform to support 
diffusion of innovative health practices along a global 
community continuum and illustrates its potential use.   
 
 
1. Introduction  
 
Hospitals and health care systems in the United 
States are increasingly becoming engaged with their 
peer institutions around the world. As a result, learning 
is taking place between organizations that results in 
new opportunities, organizational growth, increased 
job satisfaction, better market position, improved brand 
recognition, and, most importantly, better health care 
provision for patients and communities alike. 
At the core of these hospital and health system 
partnerships are opportunities for reciprocal exchange 
of ideas, approaches, and expertise. Often referred to as 
international health partnerships, examples in the 
literature include collaborative trainings, research 
activities, capacity development, and service delivery 
[1]. Determining how to move medicine to places 
where there are logistical challenges, how to educate a 
diverse array of caregivers in professional and lay 
contexts, how to build the capacity of medical 
researchers, and how to leverage social support 
structures to overcome stigma about medical 
conditions are only a handful of examples that 
demonstrate innovation flow from high-income 
countries (HIC) to low- and middle-income countries 
(LMIC), a process we refer to as ‘high-low 
innovation.’ Figure 1 illustrates the role of an HIC 
healthcare institution in moving innovations in this 
direction using a number of diffusion strategies. 
 
 
Figure 1: Innovation and Diffusion Strategies 
 
The flow of innovations in the opposite direction 
is still nascent in healthcare. In this direction, HIC 
healthcare institutions discover certain medical and 
non-medical innovations that are used in LMIC to 
address the unique healthcare needs of communities 
with significant resource constraints. Examples of 
these innovations include community healthcare 
workforces to arrest HIV rates, support pregnant 
mothers, and improve mental health outcomes [2, 3]; 
mobile applications to facilitate cash transfers to help 
pay for medical care and better collect and analyze data 
[4, 5]; and devices and products that can quickly 
identify disease and support treatment [6, 7]. 
Indigenously developed in LMIC contexts to overcome 
specific community challenges and resource 
constraints, these innovations are potentially applicable 
to other regions with similar scarcity characteristics, 
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including cities and regions in HIC such as the United 
States. Water contamination issues in Flint, Michigan 
over the past several years provides an example for the 
potential application of water filters for cleaner water 
in a similar resource-limited, HIC setting. These ‘low-
high innovations’ are often referred as ‘reverse 
innovations’ and are shown in the lower part of the 
left-hand block of Figure 1.    
       The goal of this paper is to develop effective 
mechanisms to explore the viability and facilitate the 
diffusion of innovations that flow in both ‘high-low’ 
and ‘low-high’ directions, specifically from the 
perspective of an HIC healthcare institution. Diffusion, 
at its core, is a social phenomenon that is informed by 
the interconnectedness of actors involved in an 
innovation’s design, testing, communication, and, 
eventually, uptake [8]. Because it is a social process, 
innovation adoption is informed by the social and 
structural positions in which innovation disseminators 
and potential adopters respectively find themselves [9, 
10]. Thus, perceptions of credibility and effectiveness, 
along with trust and deference matter as much on the 
part of innovators and adopters as on the innovations 
themselves. Social positions and attendant hierarchies 
of innovators and adopters alike inform how well 
innovations can be diffused. 
Nowhere is this more apparent than in the 
disparity in innovation diffusion between ‘high-low’ 
and ‘low-high’ contexts. While the high-low path of 
innovation has been a widely accepted expectation and 
norm (thus, without significant barriers), challenges to 
‘low-high’ diffusion have included regulation hurdles, 
legal barriers, and stigmas based on negative 
perceptions regarding source location, adherence to 
quality standards, and relevance or applicability in HIC 
[11, 12]. In fact, even the name used most often in the 
literature to refer to ‘low-high’ innovations (i.e. 
‘reverse innovation’) implies a negative connotation 
that many, including these authors, find problematic 
[12]. 
Indeed, this diffusion disparity is reflected through 
the lowest-shelf placement of use-and-throw shaving 
razors and the relegation of sachet-shampoo in big-box 
stores to the travel-size and sample bins. In comparison 
to pricey and branded products, these ‘good enough’ 
products are considered ‘cheap’ and ‘lackluster.’ Such 
perceptions and connotations lead to feelings of 
disenchantment and rejection for low-high innovations. 
The research question, therefore, is especially 
concerned with developing an approach that addresses 
challenges associated with diffusion of innovations 
within low-high contexts, while keeping intact the 
underlying integrity and value of the innovations 
across the adoption process and engaged societal 
contexts.  The paper is organized as follows: 
Section Two discusses diffusion theory and 
highlights a specific approach called ‘design for 
diffusion.’ Sections Three and Four describe a case 
study to demonstrate how this approach has facilitated 
the successful diffusion of two innovations within a 
low-high context. Based on this experience, Section 
Five proposes a generalizable platform to support the 
bidirectional flow of innovations for diffusion in both 
high-low and low-high contexts. Section Six provides 
some concluding comments and directions for future 
research. 
 
2. Prior research  
 
Diffusion theory has been well-documented in the 
literature. Beginning with Everett Rogers’ seminal 
work in 1962, researchers have applied and revised his 
tenets that inform how and whether an innovation will 
diffuse across domains and fields of interest [13]. 
Rogers and scholars that followed him cite common 
innovation attributes that either facilitate or prevent 
diffusion from occurring. These include an 
innovation’s compatibility to existing approaches, 
costs of success or failure, simplicity to adopt, 
potential effectiveness, whether effectiveness has been 
or can be observed, and the ease with which 
innovations can be informally trialed [8]. The 
dynamics of innovation diffusion in the healthcare 
industry are complex. New medical and information 
technologies often follow a slow pace of adoption in 
healthcare, and the speed at which diffusion occurs is 
also slow. The number of stakeholders in healthcare 
potentially affected by a technology adoption decision 
varies. For example, a clinician has to consider 
reimbursement, policy, and organizational models 
beyond the impact of a technology on patient and 
practice of care. Rogers’ change agent factor, i.e., an 
individual who influences clients’ innovation decisions 
in a direction deemed desirable by an agency, is 
predominant in the healthcare sector, where almost 
60,000 pharmaceutical sales representatives, as change 
agents, influence innovation decisions. Thus, arguably, 
within healthcare, it is pointed out that diffusion often 
occurs because of intentional dissemination activities, 
not the strength of evidence alone [8]. 
For resource-constrained populations seeking high 
quality health outcomes, there are additional challenges 
for innovation diffusion and uptake besides intention to 
adopt or strength of evidence. In these environments, 
individuals often cannot afford to pay high sums to 
achieve the desired outcomes. In settings where 
infrastructure and onerous regulation are either 
underdeveloped or absent, the environment is prime for 
creating product and technology innovations to 
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facilitate training, education, quality healthcare 
delivery, data collection, logistics management, and 
workforce deployment. In these settings, innovations 
must apply to broad populations for economies of scale 
to achieve profitability, and the chosen diffusion 
models must help address a challenging environment 
or organizational context to nurture a creative, 
sustainable solution to achieve health and wellness.  
Understanding the contexts within which these 
scarcity-informed innovations are developed is a 
necessary precursor to describing and eventually 
winning support for diffusion. The term reverse 
innovation (RI) was coined to describe the flow of 
innovative ideas from lower to higher income settings 
[14]. As applied to healthcare, DePasse and Lee define 
reverse innovation as “learning from and investing in 
poorer settings as one way to tackle problems in 
wealthier settings that require out-of-the-box solutions” 
[15]. (Note: when the authors refer to ‘out-of-the-box’ 
they mean it in the sense of approaches that break the 
mold and are new and innovative, not in the sense of a 
pre-packaged, boxed ideas.) The secret to a reverse 
innovation paradigm shift is to look for “value for 
many” instead of “value for money” [16]. Rising 
healthcare costs, insufficient insurance coverage, 
inefficient public transportation, health illiteracy, and a 
lack of trust in the health system are only a few of the 
many factors that require a new paradigm for 
healthcare innovations in the US and other HICs. 
The literature on innovation diffusion theory is 
overwhelmingly source agnostic, which complicates 
the study of low-high innovation diffusion. Dearing 
and colleagues offer one theoretical platform that may 
be a useful starting point for exploring and explaining 
the differences in how to diffuse innovations in both 
‘high-low’ and ‘low-high’ directions: designing for 
diffusion [8]. “Designing for diffusion is the taking of 
strategic steps early in the process of creating and 
refining an evidence-based intervention to increase its 
chances of being noticed, positively perceived, 
accessed, and tried and then adopted, implemented, 
and sustained in practice” [8]. Using Dearing et. al.’s 
designing for diffusion approach, the authors aim to 
explore the research question by examining a case 
study of an HIC healthcare institution that has 
successfully facilitated bidirectional global innovation 
flow. 
 
3. Research methodology 
 
Henry Ford Health System (HFHS), headquartered 
in Detroit, Michigan, is a leading US healthcare 
provider, comprised of hospitals, medical centers, a 
health plan, and one of the nation's largest group 
practices, the Henry Ford Medical Group. The Henry 
Ford Global Health Initiative (GHI) works 
with healthcare partners in LMIC around the world to 
co-develop medical capacity through training, research, 
and exchange activities. Over time, as its program 
relationships deepen, GHI learns about the innovative 
solutions its partners and local communities use 
to deliver healthcare services, deploy new workforces, 
sustainably finance care, and share and 
analyze information. Especially promising innovations 
are identified and vetted for future adaptation and pilot 
in Detroit, to improve the health of underserved 
populations at home. This reciprocal innovation flow 
of high-low capacity development and low-high 
‘reverse innovation’ defines GHI's approach to 
achieving equitable global health development and 
serves as an enduring model of transformative 
partnerships in healthcare.   
We follow the case study methodology to illustrate 
how the design for diffusion approach can help 
structure the activities of GHI over the last few years. 
Creswell et. al. [17] define the case study method as “a 
qualitative approach in which the investigator explores 
a bounded system (a case)… over time through 
detailed, in-depth data collection involving multiple 
sources of information (e.g., observations, interviews, 
audiovisual material, and documents and reports) and 
reports a case description and case-based themes” [17]. 
Over the course of 18 months, the authors 
systematically categorized and refined the types of 
‘high-low’ and ‘low-high’ innovations being shared. 
Interviews were conducted with leaders at the HIC 
institution, their respective LMIC partner institution 
stakeholders and innovators, global thought leaders in 
the nascent field of ‘reverse’ innovation, and quality 
improvement advisers from leading healthcare 
institutions in the US.  
Table 1 describes the interviews, timeline, and 
themes explored. In-depth notes from interviews were 
taken and shared among the authors, who spent three 
months surfacing themes, reconciling interpretations, 
and drawing conclusions. Extant evaluation data of the 
case study institution’s programs were reviewed and 
analyzed to build the case description and surface 
themes. Using the principles of grounded theory and 
thematic analysis, the authors developed various 
diffusion methods that evolved in their practice, and 
this is discussed next.  
 
Table 1: Representative Summary of Field Level 
Interactions and Sources 
 
Interviewees  Total hours spent in every 
year for direct interview & 
unstructured interactions  
Interview Themes 





3     Broad vision, strategy, and leadership 
contexts; overarching opportunity for 
global health leadership 
CEO of Medical 
Group 
 2 2 2 2 Role of medical training and research 





   3 3 Value proposition and alignment with 




 3 3 3 2 Role of technology and digital 
innovations to support business case 
Chief Wellness & 
Diversity Officer 
 6 4 8 7 Underserved communities; opportunities 
for local impact, engagement, and a 
focus on equity 
SVP, Population 
Health 
   2 8 Value-based and risk-based models to 
structure and facilitate tests of change 
Clinical staff, nurse 
managers 
8 8 6 8 10 Workflows, opportunities to achieve 
efficiency, scope of practice concerns, 
barriers, passion & satisfaction 
Patients & 
consumers (n=40) 
10 10 10 10 10 Social determinants of health; local 




 6 10 12 10 Network & collaboration opportunities; 
efforts to achieve complementarity in 
service provision 
 
Dearing et al’s design of diffusion process has four 
phases [8]. The first, agenda-setting and assessing 
readiness, begins before GHI engages its partners. For 
‘high-low’ innovations, these are long-time and newly 
identified partners in the ministry of health, 
universities, health systems, and non-governmental 
organizations (NGO) in LMIC. For ‘low-high’ 
innovations, these are internal health system 
department leaders and clinicians, as well as local and 
regional community partners. A year-long strategy 
alignment process within HFHS led GHI to identify 
five priority health topics with relevance to the health 
system, to Detroit, and to the entire world. After 
conducting structured in-depth interviews and focus 
group conversations with patients, health system 
leadership, and community representatives, and a 
serious review of the literature, five priority topics 
emerged: infant and maternal health, mental health, 
metabolic health, sexual and reproductive health, and 
stewardship of antibiotics. Only after categorizing its 
strengths and expertise, and contextualizing these with 
an acute awareness of its weaknesses, did GHI 
approach its partners to learn their needs and receive 
direction in how best to co-develop capacity and/or 
import innovative solutions. 
The second design for diffusion step is 
dissemination and distribution. Using inductive 
methods, GHI categorized the public health practices it 
has used globally into six types of innovations, in 
alignment with WHO’s building blocks of health 
systems [18]: Healthcare service delivery innovations 
to train medical institutions and local communities in 
improvement of preventive and secondary medical care 
delivery; workforce innovations, such as deploying 
alternative workforces and/or training clinicians with 
research skills to better collect, analyze, and diffuse 
data and care practices; health information innovations, 
which include the technology and data collection and 
analysis applications to track and monitor health 
outcomes; product innovations, which include the 
vaccines, devices, and technologies used to facilitate 
healthcare delivery and improvement; health financing 
innovations that ensure sustainable health care delivery 
through payment and reimbursement mechanisms; and 
policy innovations, including rules, regulations, 
policies, and standard operating procedures to improve 
quality and efficiency of care. These six innovation 
types represent a starting point from which GHI’s 
partners can identify opportunities for innovation flow 
to occur. Table 2 includes examples of community-
expressed goals (i.e. phase one: agenda setting) and the 
relevant types of innovations selected for pilot projects 
for diffusion (i.e. phase two: dissemination and 
distribution). 
 
Table 2. Examples of Paired Community Needs to 
Innovation Types 
 
Community Goal  Innovation Model  
Reduce overall time to train 
medical specialists 
Process innovation: Introduce 
specialist surgical ‘boot camp’ training 
model 
Improve research skills and 
increase publications of early- 
and mid-stage medical staff 
Practice innovation: Jointly created 
mixed-methods research design & 
training in-service short-course for 
hospital staff 
Maintain strict adherence to 
existing laws and prevent 
public smoking/tobacco use 
Policy innovation: Public advocacy 
campaign and engagement with senior 
management to obtain support  
  
The examples listed in Table 2 must be further 
contextualized and refined by the characteristics of the 
stakeholders whose engagement and acceptance will 
define their diffusion. Such contextualization can be 
based on diffusion strategies discussed earlier [12] (e.g. 
evidence, trialability, simplicity, etc.), as well as 
several other factors, such as adopter behavior, 
innovation type, and relative advantage. Consideration 
of these factors constitutes Dearing et al’s third phase, 
which consists of engaging and winning over 
influential stakeholders, gatekeepers, and community 
representatives “whose trustworthiness and expertise 
serve as social confirmation” that an innovation can be 
successfully adopted [8]. As noted earlier, diffusion is 
a social process, which means that the beliefs, 
perceptions, and prejudices of adopters and innovators 
alike converge to inform whether or not innovations 
will even be selected for pilot and/or adaptation, let 
alone fully diffused. This seldom prevents GHI’s 
‘high-low’ innovation diffusion from occurring 
successfully, but it has been a continual barrier to 
successful ‘low-high’ innovation flow. 
Only by convincing decision-makers and key 
influencers of these innovations’ merits can GHI move 
on to Dearing et al’s fourth and final phase of diffusion 
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design, which is implementation into practice settings. 
GHI has undertaken two such implementations over 
the last two years - providing access to mental health 
care and supporting access to care for homeless, young 
LGBTQ individuals, and these will be discussed in the 
next section. 
 
4. Results    
 
4.1 Mental Health Prevention 
 
Providing access to mental healthcare to 
populations in Detroit is challenging because many 
patients lack transportation, do not have a single point 
of contact with behavioral health or psychiatry 
services, mistrust the health system, and are under- or 
uninsured. Poor reimbursement levels and high 
appointment cancellation rates also lead to waiting lists 
that last several months, which can deter patients and 
reinforce the high price of mental healthcare.  
One of GHI’s long-term partners in a South Asian 
LMIC identified an approach it used to construct 
healthcare infrastructure in a sparsely populated, 
rugged, mountainous setting. Their setting required 
innovative approaches to maximize reach (i.e. 
decentralize the workforce), while minimizing costs 
(i.e. centralize capital and infrastructure). A service 
delivery innovation called ‘hub and spoke’ guided the 
establishment of health outposts in informal settings 
like temples, schools, and municipal offices, which all 
became spokes that were connected back to a central 
‘hub’ hospital. A workforce innovation was developed, 
whereby community health workers (CHWs) were 
trained and equipped at the hub and then returned to 
their villages to staff the spokes. Given that they were 
usually the first and only point of contact for remote 
villagers, CHWs helped improve chronic disease 
management, contraceptive use prevalence, and 
institutional births. Feedback from the CHWs revealed 
a need for training in mental health first aid to address 
contextual drivers of illness and disease [19]. 
GHI adapted the hub and spoke model for use in 
Detroit to improve mental health treatment rates among 
low-income adult patients of HFHS. A mental health 
psychotherapist was integrated within the primary care 
office by utilizing video technology. When patients 
came to see their doctor and displayed a mild to 
moderate mental health condition, they could see a 
therapist in the same location on the same day. As a 
follow-up, trained CHWs visited the patient at home or 
over the phone, depending on preference, to conduct 
motivational interviewing and connect the patient with 
resources to sustain their positive health outcomes. 
This is just one illustration of how reverse innovation 
can improve care delivery.  
 









Hub and spoke 
service delivery 
model 
Complementarity to existing 
HFHS medical infrastructure; 
promise of effectiveness to reduce 






health product and 
health information 
model 
Low-cost and identification of 
reimbursement mechanism for 
both telehealth and CHWs 
deployment; Regard for patient 
feedback and satisfaction  
 
Table 3 summarizes the core drivers that guided its 
use of Dearing et al’s third and fourth phases to 
achieve diffusion of a ‘low-high’ innovation in Detroit. 
 
4.2 LGBTQ Peer Empowerment and Health 
Navigation 
  
GHI recently partnered with a Detroit-area 
nonprofit organization serving young, homeless, 
LGBTQ people. Nationally, LGBTQ identity among 
youth correlates with a 2.2 times increased risk for 
homelessness [20]. Young people in Detroit who 
identify themselves as LGBTQ struggle with housing 
insecurity, and nearly 40% are HIV positive. GHI’s 
partnership seeks to innovatively reduce the rate of 
HIV incidence and increase access to testing, pre-
exposure prophylaxis (PrEP), and education. Because 
of the correlation between homelessness and poor 
health outcomes, GHI searched innovation databases 
and among partners for approaches that factored in 
employment and income in its search. Additionally, 
because of the unique population being served, search 
criteria included marginalized and vulnerable 
demographic subgroups. The resultant search led to a 
unique solution that addressed income insecurity (as a 
proxy for homelessness) and limited access to HIV 
education, testing, and therapy. A health workforce 
innovation being used in a Southeast Asian LMIC was 
identified for adaptation and testing. 
The source partner in Southeast Asia shared many 
of the Detroit partner’s context challenges: urban 
density of the subject population (young, LGBTQ); 
experiences of stigma and rejection; broad societal 
recognition of LGBTQ identity; high-income 
insecurity; and high rates of HIV incidence. Given the 
similarities, conversations were initiated by GHI to 
discern how the Southeast Asia-based partner had 
recruited, hired, trained, deployed, and retained 
housing-insecure LGBTQ young people in community 
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health worker positions to help their peers navigate 
their HIV care and prevention activities. 
Two project initiatives have grown out of the 
connection facilitated via GHI between the Detroit and 
the Southeast Asia community organizations. First, a 
Detroit pilot was initiated, modeled off the peer health 
navigator effort, to adapt training and retention 
modalities among Detroit young people to serve in a 
similar role. Second, a community health worker 
exchange was developed for peer navigators in both 
settings to connect virtually in order to create a co-
located “community of practice” exchange of cultural 
lessons, best practices, strategies, and support for HIV 
care. 
In both examples, GHI started from a deep 
understanding of local problems. However, the two 
cases present slightly different approaches to 
identifying solutions. For mental health, GHI utilized a 
long-standing partner to identify the solution, while for 
the sexual and reproductive health case study, GHI 
scanned databases and external relationships to identify 
a promising solution. 
These case studies led GHI to conclude that 
implementation challenges associated with diffusing 
such innovations as well as opportunities for 
identifying innovations that can support healthcare 
need a generalizable framework in line with supporting 
Dearing et al’s four phases. In other words, what is 
needed is a source-agnostic, technology-facilitated 
platform capable of capturing and diffusing 
innovation-specific knowledge to facilitate diffusion.  
In today’s complex market dynamic, organizations 
are developing innovative products and services, often 
supported by information technologies, to stay 
effective and competitive in fulfilling their vision. To 
create value, these innovations must be explored at an 
ever-faster speed. Leading the innovation process using 
enabling and adaptive leadership is important, along 
with the administrative leadership to run the regular 
business [21, 22]. HFHS, with all the global 
communities it serves, has an extended healthcare 
network. GHI facilitates the “adoption” by LMIC 
communities of innovative public health practices 
generated within the US, while simultaneously 
“enabling” the evaluation and adaptation of ideas 
generated within its global community network for 
potential adoption in the US.   To support low-high and 
high-low innovation dissemination, GHI needs an 
innovation fostering platform that helps support the 
coordination of multiple stakeholders in the 
exploration, learning, adaptation, and evaluation of 
both forward and reverse innovations, as it designs 
diffusion strategies to address global community needs. 
The following section proposes the development of a 
global health innovation platform (GHIP) to support 





5.1. GHIP Model for Platform Development 
 
The GHIP platform captures the knowledge of all 
public healthcare practices that are diffused to various 
communities successfully, as well as those that are 
successful in one community with a potential for 
exploration elsewhere. It also captures community 
efforts that make adaptations successful for any 
number of reasons, as these can be helpful in future 
decisions related to adoption and diffusion. The 
platform has three underlying mechanisms to foster 
innovation. The three mechanisms foster innovation by 
supporting (1) information integration and knowledge 
coordination; (2) multi-stakeholder engagement to 
scout, share, and disseminate knowledge to foster 
innovation; and (3) servitization and productization 
agility to create products and processes that support 




Figure 2: The Innovation Fostering Activities of a 
Global Health Platform 
 
5.2 Information integration and knowledge 
coordination 
 
When knowledge within a firm is isolated within 
the boundaries of a sub-unit, it hinders the capacity of 
an organization to recombine it in the quest for 
innovation [23]. Interdepartmental separation and lack 
of co-ordination results in poor understanding and low 
synchronization of the knowledge needed to develop 
new products [24]. Integration across organizational 
silos can help overcome barriers to the continuous 
expansion of knowledge, and such knowledge 
accumulation is needed to facilitate the generation of 
novel ideas and create new knowledge [25]. Innovation 
requires the creation of knowledge and the sharing of 
this knowledge to mobilize action towards problem 
solving [8], and the mechanism proposed supports such 
a sharing of knowledge across organizational silos. 
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Similarly, the importance of access to knowledge for 
innovation is well recognized (e.g. [26, 27]). Access to 
knowledge here refers to the availability of knowledge 
from multiple sources to help workers within a firm 
improve their potential to innovate [28]. Building 
knowledge to support access requires the 
documentation of various diffusion models, 
contextualized by community characteristics.  
GHI has both an opportunity and a capability to 
create a knowledge repository of healthcare practices 
that can be used for search and retrieval. This was 
illustrated with the use of the hub and spoke model to 
support mental health rehabilitation in the US.  
 
5.3. Fostering innovation through multi-
stakeholder engagement 
 
An innovative ecosystem within an organization 
strives to improve links across different units, agents, 
and stakeholders to support alignment of two different 
mindsets or perspectives: an innovative mindset that is 
non-linear in thinking and risk-taking, and a business 
mindset that is methodical and somewhat risk-averse in 
its calculation of return on investment. A platform can 
act as a bridge between these two by collecting ideas, 
openly and/or anonymously, for consideration as a way 
to allow unbiased, non-linear thinking. It can then 
publish selected ideas and the criteria used for their 
support to convey a business case on risks, returns, and 
value. Such a clear articulation of the thinking that 
went into submission and selection can lead to 
informal discussion and continual refinement over 
time, thus bridging the gap between these two different 
mindsets. More importantly, people over time can 
engage in brainstorming ideas and their prioritization 
using a broader view of how to support a culture of 
innovation.    
For example, those seeking grants to support public 
health practice diffusion may need to adopt a business 
mindset to articulate measurable value propositions, 
while those responsible for diffusing the practice into a 
global community need to embrace non-linear thinking 
and some risk-taking. Bridging these two perspectives, 
while a challenge, can also lead to opportunities over 
time if prior knowledge can be used to help either 
develop a new approach or evaluate the viability of an 
existing approach.  
The individual researchers and global community 
practitioners can each act as consultants or observers in 
the exploration and diffusion process. Enabled by the 
platform, GHI can help bridge the differences in the 
perspectives each one will bring.  
 
5.4. Productization and servitization agility 
 
Dynamic capabilities theory argues that agility is a 
key for innovation [29]. This theory posits that 
dynamic capabilities are important contributors to an 
organization’s ability to change and adapt. Innovative 
organizations that produce products need servitization 
agility (the ability of a business to adapt to changing 
conditions that demand services) and productization 
agility (the ability to use innovation-to-product 
architecture by creating products from services) [30]. 
While most product companies that want to be active 
in providing services will design these products for 
service, many service companies must convert their 
practice knowledge into products.  
Servitization for GHI may include modularizing 
healthcare practices in components that can act as 
training modules for care providers (e.g. nurses or 
community health workers), mobile apps that can 
provide step-by-step implementation of practice 
knowledge, or products with embedded AI. An 
illustration of the last example is a medical device that 
draws blood and has an intelligent agent that poses 
questions regarding the context before blood is drawn 
or after for storage. The resulting knowledge 
repositories can lead to opportunities for creating 
“products” (servitization) that can have broader use 
and potential commercialization.  
GHI can be a vehicle for such servitization and has 
already demonstrated it through its bootcamp program 
used to provide standardized training discussed in 
Table 2.   
In summary, GHI acts as catalyst to foster public 
healthcare practice diffusion by bridging the mindset of 
those with both linear and non-linear thinking and 
leverage the knowledge base in support of exploration 




Lack of confidence in the quality and effectiveness 
of a practice that worked in a developing country and 
its adaptability to the US context is a major challenge 
in moving innovations freely across a global network. 
GHI addresses this challenge by evaluating innovative 
healthcare practices on clinical quality and 
effectiveness. While this evaluation is value agnostic 
with respect to the geographic, social, and cultural 
settings from within which the innovation originates, 
GHI has to pay particular attention to the contextual 
factors that both the innovation source and the 
recipient have in common. Using many elements GHI 
used in the diffusion of public health practices across 
the global network, the paper proposes a GHIP 
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platform to support the identification of innovation 
types for diffusing public health practices.  
Using a taxonomy for the characterization and 
searchability of these innovations, GHI can support 
dialogue, positively influence mindsets, and support 
both linear and non-linear thinking among multiple 
stakeholders to support the wider sharing of practices 
that have shown value. Believing that there is much 
more that global communities share with one another 
than separately define them, GHI offers GHIP as a 
model of equity-building in innovation diffusion, as 
well as a functional tool to identify opportunities for 
servitization of diffusion models for faster deployment 
in the future. We conclude by suggesting three future 
research directions to facilitate global value co-
creation, partnerships, and improved search to nurture 
innovation flow.  
 
6.1. Opportunities for collaborative value 
creation 
 
While the current GHI model creates value through 
co-design of methods captured in its knowledge 
repository by contextualizing these to the social 
context, it sees potential to co-create value through 
collaboration. As it solicits ideas from the local 
community for public healthcare practices that can 
address a key need, it can concurrently search the 
knowledge base to identify practices that were diffused 
effectively in communities at large with similar social, 
economic, technical, and educational challenges. Such 
practices can be shared with communities it serves 
(e.g. Detroit) and let these communities identify their 
potential as well as challenges. Such a process can be 
reversed as well, with the global community 
identifying a need and the US community sharing what 
worked for them. This public-to-public collaboration 
model can be enabled by GHI and fine-turned by the 
various internal HFHS teams before pilot testing in the 
community begins. This enables HFHS to focus on the 
specific clinical or population health aspects of the 
practice, while the larger community (public) can, in 
collaboration with GHI, decide on its social relevance.  
 
6.2. Partnership for Diffusion of Practice 
 
GHI, using the GHIP platform, can start to build an 
extensive repository of innovations over the course of 
several years of research, training, and capacity 
building activities around the world. While some of 
these innovations can be broader in focus, GHI can 
narrowly define some it can lead, based on the skillset 
of its labor force, the leveragability of 
multidisciplinary relationships with medical providers 
and experts from across the health system, and a 
careful examination of the most salient health 
challenges in the area it serves. However, it may 
choose to partner with other healthcare organizations 
if a community decides the appropriateness of some 
innovations outside its focus area.  
 
6.3. Innovation Search Criteria 
 
Both collaboration and partnerships can be 
supported if the search criteria used to identify 
innovations in the knowledge repository can be 
expanded.  At this time, the topics on which the search 
can be conducted include: source of innovation (where 
it is developed); income status of source (on some 
metric such as GDP); population density; religious, 
ethnic, racial, or demographic characteristic(s); and 
type of innovation. Other types of information can be 
added, such as who implemented the innovation; 
characteristic(s) of the innovation recipient or 
beneficiary; and contextual considerations of the 
source that adopted the innovation (e.g. limited 
transportation infrastructure, high access challenge, 
severe uptick of a disease, etc.). By gathering such 
data, innovation type search by communities can also 
be supported with the influencers who played a role in 
their implementation as well as any other value 
propositions, all supporting the first two phases of 
design for diffusion among global communities GHI 
serves.   
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